49 min listen
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
ratings:
Length:
48 minutes
Released:
Oct 9, 2023
Format:
Podcast episode
Description
Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.
Released:
Oct 9, 2023
Format:
Podcast episode
Titles in the series (100)
HOU1 2009 | Interview with Stephanie A Gregory, MD: ResearchToPractice.com/HOU – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice. by Hematologic Oncology Update